These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2486158)

  • 1. Lipofuscin-like substances accumulate rapidly in brain, retina and internal organs with cysteine protease inhibition.
    Ivy GO; Kanai S; Ohta M; Smith G; Sato Y; Kobayashi M; Kitani K
    Adv Exp Med Biol; 1989; 266():31-45; discussion 45-7. PubMed ID: 2486158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leupeptin causes an accumulation of lipofuscin-like substances in liver cells of young rats.
    Ivy GO; Kanai S; Ohta M; Sato Y; Otsubo K; Kitani K
    Mech Ageing Dev; 1991 Mar; 57(3):213-31. PubMed ID: 2056777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitors as a model for NCL disease, with special emphasis on the infantile and adult forms.
    Ivy GO
    Am J Med Genet; 1992 Feb; 42(4):555-60. PubMed ID: 1376968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological, physiological and biochemical alterations in livers of rodents induced by protease inhibitors: a comparison with old livers.
    Kitani K; Ohta M; Kanai S; Nokubo M; Sato Y; Otsubo K; Ivy GO
    Adv Exp Med Biol; 1989; 266():75-92. PubMed ID: 2486165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leupeptin causes an accumulation of lipofuscin-like substances and other signs of aging in kidneys of young rats: further evidence for the protease inhibitor model of aging.
    Ivy GO; Roopsingh R; Kanai S; Ohta M; Sato Y; Kitani K
    Ann N Y Acad Sci; 1996 Jun; 786():12-23. PubMed ID: 8687013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural observations on neuronal lipofuscin (age pigment) and dense bodies induced by a proteinase inhibitor, leupeptin, in rat hippocampus.
    Nunomura A; Miyagishi T
    Acta Neuropathol; 1993; 86(4):319-28. PubMed ID: 8256581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain.
    Ivy GO; Schottler F; Wenzel J; Baudry M; Lynch G
    Science; 1984 Nov; 226(4677):985-7. PubMed ID: 6505679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of lipofuscin-like fluorescence in the retinal pigment epithelium in response to protease inhibitor treatment.
    Katz ML; Shanker MJ
    Mech Ageing Dev; 1989 Jul; 49(1):23-40. PubMed ID: 2747298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protease inhibitor leupeptin induces several signs of aging in brain, retina and internal organs of young rats.
    Ivy GO; Ihara Y; Kitani K
    Arch Gerontol Geriatr; 1991; 12(2-3):119-31. PubMed ID: 15374443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin A incorporation into lipofuscin-like inclusions in the retinal pigment epithelium.
    Katz ML; Gao CL
    Mech Ageing Dev; 1995 Sep; 84(1):29-38. PubMed ID: 8719775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-induced fluorescence in the retina: dependence on vitamin A.
    Katz ML; Christianson JS; Gao CL; Handelman GJ
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3613-24. PubMed ID: 8088951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible accumulation of lipofuscin-like inclusions in the retinal pigment epithelium.
    Katz ML; Rice LM; Gao CL
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):175-81. PubMed ID: 9888441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dietary vitamin A on autofluorescence of leupeptin-induced inclusions in the retinal pigment epithelium.
    Katz ML; Norberg M
    Exp Eye Res; 1992 Feb; 54(2):239-46. PubMed ID: 1559552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lipofuscin on the retinal pigment epithelium: electroretinographic evaluation of a protease inhibition model.
    Rapp LM; Fisher PL; Sheinberg CH
    Graefes Arch Clin Exp Ophthalmol; 1994 Apr; 232(4):232-7. PubMed ID: 8034212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and pathological alterations following infusion of leupeptin, a protease inhibitor, into the rat brain.
    Kuki K; Maeda K; Takauchi S; Kakigi T; Maeda S; Tanaka C
    Dementia; 1996; 7(5):233-8. PubMed ID: 8872412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of lipofuscinogenesis: effect of the inhibition of lysosomal proteinases and lipases under varying concentrations of ambient oxygen in cultured rat neonatal myocardial cells.
    Marzabadi MR; Sohal RS; Brunk UT
    APMIS; 1991 May; 99(5):416-26. PubMed ID: 2043354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RPE65 gene mutation prevents development of autofluorescence in retinal pigment epithelial phagosomes.
    Katz ML; Wendt KD; Sanders DN
    Mech Ageing Dev; 2005 Apr; 126(4):513-21. PubMed ID: 15722110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lovastatin and leupeptin on ceroidogenesis of vitamin E-deficient and -supplemented young rats.
    Porta EA; Monserrat AJ; Berra A; Rubio MC
    Adv Exp Med Biol; 1989; 266():169-88; discussion 189-90. PubMed ID: 2486149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced lysosomal disorders in laboratory animals: new substances acting on lysosomes.
    Schneider P
    Arch Toxicol; 1992; 66(1):23-33. PubMed ID: 1349805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipofuscin turnover.
    Boulton M; Davies S; Ellis S
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1887-8. PubMed ID: 10393067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.